世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国における核酸ベースのマルチプレックスアッセイの市場規模、現状、予測2021-2027年


Global and China Nucleic Acid-Based Multiplex Assays Market Size, Status and Forecast 2021-2027

マルチプレックスアッセイとは、様々な分析物(タンパク質、生体分子、成長因子、サイトカイン、ケモカインなど)を同時に検出・定量することでプロファイリングを行う方法です。このアッセイは、ポリメラーゼ連... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年10月14日 US$3,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

マルチプレックスアッセイとは、様々な分析物(タンパク質、生体分子、成長因子、サイトカイン、ケモカインなど)を同時に検出・定量することでプロファイリングを行う方法です。このアッセイは、ポリメラーゼ連鎖反応(PCR)で複数の標的を増幅し、ELISAなどの従来の方法と比較して、より少ない時間で微量のタンパク質やその他の分析物からより多くの情報を収集するために使用されます。マルチプレックスアッセイは、病原体の同定、突然変異解析、RNA 検出、遺伝子検出解析、連鎖解析、法医学研究などに広く利用されています。

市場分析とインサイト核酸ベースのマルチプレックスアッセイの世界市場
核酸ベースのマルチプレックスアッセイの世界市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルに達すると予測され、2021年から2027年の間、XX%のCAGRで推移すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のNucleic Acid-Based Multiplex Assays市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、核酸ベースマルチプレックスアッセイの世界市場全体の規模(売上高)など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、核酸ベースマルチプレックスアッセイの世界市場において、競合他社よりも優位に立ち、永続的な成功を収めるための効果的なツールであることがわかります。本レポートに掲載されている調査結果、データ、情報はすべて、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、核酸ベースマルチプレックスアッセイの世界市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の核酸ベースマルチプレックスアッセイの概要と市場規模
核酸ベースのマルチプレックスアッセイ市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されます。世界のNucleic Acid-Based Multiplex Assays市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
試薬・消耗品
機器・アクセサリ
ソフトウェア&サービス

アプリケーション別セグメント
コンパニオン診断薬
研究・開発
臨床診断薬

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
Luminex
サーモフィッシャーサイエンティフィック
イルミナ
バイオラッドラボ
QIAGEN
BD
アブカム
シージーン
メソスケール・ダイアグノスティクス
ランドックス・ラボラトリーズ


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents & Consumables
1.2.3 Instruments & Accessories
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Companion Diagnostics
1.3.3 Research & Development
1.3.4 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2016-2027)
2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions
2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2016-2021)
2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027)
2.3 Nucleic Acid-Based Multiplex Assays Industry Dynamic
2.3.1 Nucleic Acid-Based Multiplex Assays Market Trends
2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers
2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges
2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2016-2021)
3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2016-2021)
3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue
3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2020
3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2016-2021)
4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027)

5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2016-2021)
5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
6.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type
6.2.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
6.2.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
6.2.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application
6.3.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
6.3.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
6.3.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country
6.4.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
6.4.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type
7.2.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
7.2.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
7.2.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application
7.3.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
7.3.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
7.3.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country
7.4.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
7.4.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type
9.2.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
9.2.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
9.2.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application
9.3.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
9.3.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
9.3.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country
9.4.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
9.4.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Luminex
11.1.1 Luminex Company Details
11.1.2 Luminex Business Overview
11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction
11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.1.5 Luminex Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction
11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.3.5 Illumina Recent Development
11.4 Bio-Rad Lab
11.4.1 Bio-Rad Lab Company Details
11.4.2 Bio-Rad Lab Business Overview
11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction
11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.4.5 Bio-Rad Lab Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Details
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction
11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.5.5 QIAGEN Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.6.5 BD Recent Development
11.7 Abcam
11.7.1 Abcam Company Details
11.7.2 Abcam Business Overview
11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction
11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.7.5 Abcam Recent Development
11.8 Seegene
11.8.1 Seegene Company Details
11.8.2 Seegene Business Overview
11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction
11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.8.5 Seegene Recent Development
11.9 Meso Scale Diagnostics
11.9.1 Meso Scale Diagnostics Company Details
11.9.2 Meso Scale Diagnostics Business Overview
11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction
11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.9.5 Meso Scale Diagnostics Recent Development
11.10 Randox Laboratories
11.10.1 Randox Laboratories Company Details
11.10.2 Randox Laboratories Business Overview
11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction
11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.10.5 Randox Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.

Market Analysis and Insights: Global Nucleic Acid-Based Multiplex Assays Market
The global Nucleic Acid-Based Multiplex Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid-Based Multiplex Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid-Based Multiplex Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid-Based Multiplex Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid-Based Multiplex Assays market.

Global Nucleic Acid-Based Multiplex Assays Scope and Market Size
Nucleic Acid-Based Multiplex Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-Based Multiplex Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services

Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-Based Multiplex Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents & Consumables
1.2.3 Instruments & Accessories
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Nucleic Acid-Based Multiplex Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Companion Diagnostics
1.3.3 Research & Development
1.3.4 Clinical Diagnostics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nucleic Acid-Based Multiplex Assays Market Perspective (2016-2027)
2.2 Nucleic Acid-Based Multiplex Assays Growth Trends by Regions
2.2.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nucleic Acid-Based Multiplex Assays Historic Market Share by Regions (2016-2021)
2.2.3 Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Regions (2022-2027)
2.3 Nucleic Acid-Based Multiplex Assays Industry Dynamic
2.3.1 Nucleic Acid-Based Multiplex Assays Market Trends
2.3.2 Nucleic Acid-Based Multiplex Assays Market Drivers
2.3.3 Nucleic Acid-Based Multiplex Assays Market Challenges
2.3.4 Nucleic Acid-Based Multiplex Assays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid-Based Multiplex Assays Players by Revenue (2016-2021)
3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2016-2021)
3.2 Global Nucleic Acid-Based Multiplex Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid-Based Multiplex Assays Revenue
3.4 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid-Based Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-Based Multiplex Assays Revenue in 2020
3.5 Nucleic Acid-Based Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Nucleic Acid-Based Multiplex Assays Product Solution and Service
3.7 Date of Enter into Nucleic Acid-Based Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-Based Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Type (2016-2021)
4.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Type (2022-2027)

5 Nucleic Acid-Based Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid-Based Multiplex Assays Historic Market Size by Application (2016-2021)
5.2 Global Nucleic Acid-Based Multiplex Assays Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
6.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type
6.2.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
6.2.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
6.2.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
6.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application
6.3.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
6.3.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
6.3.3 North America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
6.4 North America Nucleic Acid-Based Multiplex Assays Market Size by Country
6.4.1 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
6.4.2 North America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type
7.2.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
7.2.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
7.2.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application
7.3.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
7.3.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
7.3.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
7.4 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country
7.4.1 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
7.4.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
8.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nucleic Acid-Based Multiplex Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
9.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type
9.2.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
9.2.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
9.2.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
9.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application
9.3.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
9.3.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
9.3.3 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
9.4 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country
9.4.1 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
9.4.2 Latin America Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size (2016-2027)
10.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Luminex
11.1.1 Luminex Company Details
11.1.2 Luminex Business Overview
11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Introduction
11.1.4 Luminex Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.1.5 Luminex Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Introduction
11.3.4 Illumina Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.3.5 Illumina Recent Development
11.4 Bio-Rad Lab
11.4.1 Bio-Rad Lab Company Details
11.4.2 Bio-Rad Lab Business Overview
11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Introduction
11.4.4 Bio-Rad Lab Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.4.5 Bio-Rad Lab Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Details
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Introduction
11.5.4 QIAGEN Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.5.5 QIAGEN Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Nucleic Acid-Based Multiplex Assays Introduction
11.6.4 BD Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.6.5 BD Recent Development
11.7 Abcam
11.7.1 Abcam Company Details
11.7.2 Abcam Business Overview
11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Introduction
11.7.4 Abcam Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.7.5 Abcam Recent Development
11.8 Seegene
11.8.1 Seegene Company Details
11.8.2 Seegene Business Overview
11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Introduction
11.8.4 Seegene Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.8.5 Seegene Recent Development
11.9 Meso Scale Diagnostics
11.9.1 Meso Scale Diagnostics Company Details
11.9.2 Meso Scale Diagnostics Business Overview
11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Introduction
11.9.4 Meso Scale Diagnostics Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.9.5 Meso Scale Diagnostics Recent Development
11.10 Randox Laboratories
11.10.1 Randox Laboratories Company Details
11.10.2 Randox Laboratories Business Overview
11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Introduction
11.10.4 Randox Laboratories Revenue in Nucleic Acid-Based Multiplex Assays Business (2016-2021)
11.10.5 Randox Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19 10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る